Network News

International project consortium is coordinated at Heidelberg University Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and virus replication. That is the goal of an international research project in which scientists work on new approaches to combating highly dangerous viral diseases such […]

February 19, 2025 Basel, Switzerland, 19 February 2025 – Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced today the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech for the production of catumaxomab for Commercial Supply. Catumaxomab is a first-in-class, trifunctional bispecific monoclonal antibody designed for the intraperitoneal treatment of […]

Handelsblatt | 07.02.2025 —Innovation — Deutschlands wichtigste Wette auf die Zukunft Handelsblatt Insight Biotechnologie zählt zu den vielversprechendsten Wirtschaftsfeldern. Die Bundesrepublik zeigt dabei laut einer neuen Studie überraschende Stärken. Experten sehen allerdings Probleme, die dringend gelöst werden müssen. Der deutsche Mikrobiologe Robert Koch findet 1882 den Erreger für die Krankheit Tuberkulose. 1895: Wilhelm Conrad Röntgen entdeckt in […]

BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new research initiative focused on better treatment of cardiometabolic diseases in individuals of African descent. Heidelberg, Germany / Bridgetown, Barbados – February 20, 2025. BioMed X Institute is proud to announce a partnership with the […]

Extraordinary funding from the Chan Zuckerberg Initiative supports two large collaborative projects that will boost imaging technology development By Stephanie Alexander, EMBL Imaging Centre Research & Service Coordinator Developing advanced imaging technologies is critical to advancing life sciences research. It is especially important to explore the detailed structure and function of tissues, cells, and macromolecules […]

A combination of new laboratory technology and artificial intelligence is set to make the rapid and precise differentiation of subgroups of brain tumours widely available. An international research group led by Professor Dr. Dr. Felix Sahm from the Department of Neuropathology at Heidelberg University Hospital and the Heidelberg Faculty of Medicine at Heidelberg University is […]

Approval based on positive results from Phase III ATTRibute-CM study / Beyonttra™ is a near-complete (≥90%) stabilizer of transthyretin (TTR) minimizing amyloid formation / Phase III ATTRibute-CM study with Beyonttra™ has shown clear benefits on cardiovascular endpoints already starting as early as 3 months after treatment initiation. Berlin, February 11, 2025 – The European Commission has […]

The European vaccine development ecosystem has been strengthened over the last 16 years, thanks to the EVI-led TRANSVAC project, an ambitious initiative funded by the European Commission. Since its launch in 2009, TRANSVAC has established itself as a key player in advancing vaccine research, supporting over 160 vaccine projects while fostering innovation and collaboration in […]

Zwingenberg, Germany, 4 February 2025 – Akribion Therapeutics (“Akribion”), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the completion of a Seed Financing round raising EUR 8 million to accelerate the development of novel therapeutics based on Akribion’s proprietary G-dase® E nucleases. The round […]